Rectal cancer radiotherapy: towards European consensus (Q37789029)

23 August 2017

Rectal cancer radiotherapy: towards European consensus (English)

1 reference

23 August 2017

0 references

2

Bengt Glimelius

1 reference

23 August 2017

1

Vincenzo Valentini

1 reference

23 August 2017

15 September 2010

1 reference

23 August 2017

1 reference

23 August 2017

49

1 reference

23 August 2017

8

1 reference

23 August 2017

1206-1216

1 reference

Evidence and research in rectal cancer

23 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Rectal tumor stage: correlation of endorectal MR imaging and pathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

The accuracy of Multi-detector row CT for the assessment of tumor invasion of the mesorectal fascia in primary rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Local staging of rectal cancer: assessment with double-contrast multislice computed tomography and transrectal ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Imaging for predicting the risk factors--the circumferential resection margin and nodal disease--of local recurrence in rectal cancer: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Preoperative staging of rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Prediction of rectal lymph node metastasis by pelvic computed tomography measurement.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Evaluating Mesorectal Lymph Nodes in Rectal Cancer Before and After Neoadjuvant Chemoradiation Using Thin-Section T2-Weighted Magnetic Resonance Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Management of early rectal T1 and T2 cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Preoperative staging and treatment options in T1 rectal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Is the increasing role of Transanal Endoscopic Microsurgery in curation for T1 rectal cancer justified? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Sphincter preservation in rectal cancer. Local excision followed by postoperative radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Contact X-ray therapy for rectal cancer: experience in Centre Antoine-Lacassagne, Nice, 2002-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Transanal endoscopic microsurgery for the treatment of selected patients with distal rectal cancer: 15 years experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Short-course preoperative radiotherapy with delayed surgery in rectal cancer - a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

A Systematic Overview of Radiation Therapy Effects in Rectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

The Swedish rectal cancer registry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Chemotherapy with preoperative radiotherapy in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Canc

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Preoperative versus postoperative chemoradiotherapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Phase II study of preoperative helical tomotherapy for rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: the CORGI-L Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

21 January 2018

IGRT in rectal cancer.

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.506884

10.3109/0284186X.2010.506884

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

20843179